Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma

British Journal of Ophthalmology

Volumn 93, Issue 2, 2009, Pages 273-274

  Grover, S ^a,b   Gupta, S ^a   Sharma, R ^a   Brar, V S ^a   Chalam, K V ^a  

^a UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; VASCULOTROPIN; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AQUEOUS HUMOR; CASE REPORT; DRUG EFFECT; DRUG EFFICACY; EYE PAIN; FEMALE; HUMAN; INTRAOCULAR PRESSURE; IRIS DISEASE; LETTER; LIGHT; MALE; NEOVASCULAR GLAUCOMA; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; RETINA DETACHMENT; RETINA NEOVASCULARIZATION; VISUAL ACUITY; METABOLISM; MIDDLE AGED;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; AQUEOUS HUMOR; FEMALE; GLAUCOMA, NEOVASCULAR; HUMANS; MALE; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 60849085180     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.145714     Document Type: Letter

References (4)

1. Adamis AP, Miller JW, Bernal M-T, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994;118:445-50.
2. Noma H, Funatsu H, Yamasaki M, et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 2005;140:256-61.
3. Tripathi RC, Li J, Tripathi BJ, et al. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology 1998;105:232-7.
4. Herell PK, Tripathi RC, Whiteside BC, et al. The use of contact transscleral Nd:YAG cyclophotocoagulation in neovascular glaucoma [ARVO abstract]. Invest Ophthalmol Vis Sci 1997;38:s171.